Literature DB >> 22664407

Transcultural adaptation of the Night Eating Questionnaire (NEQ) for its use in the Spanish population.

Violeta Moizé1, Marci E Gluck, Ferran Torres, Alba Andreu, Josep Vidal, Kelly Allison.   

Abstract

BACKGROUND: Establishing valid and reliable methods of assessing night eating symptoms is an important goal to maximize identification and treatment of the night eating syndrome (NES). The 14-item Night Eating Questionnaire (NEQ) is the only published and validated assessment instrument but is not yet adapted to Spanish.
METHODS: We examined the factor structure, internal consistency and validity of the NEQ in Spanish. The study had 4 phases: a) translation from English to Spanish; b) back-translation from Spanish to English, c) administration of translated version to a Spanish sample, and d) a re-test in 36 participants two weeks later. Reliability, stability, and scale structure were evaluated by Cronbach's α, test-re-test, and factor analysis, respectively. Divergent validity was assessed by correlation with the Spanish versions of the State-Trait Anxiety Inventory (STAI) and the Beck Depression Inventory (BDI-II).
RESULTS: Two-hundred forty-four individuals (181 f; BMI 34.3±10 kg/m(2); age 40.5±15 y) completed the questionnaire. The mean NEQ score was 12.5±7. The Cronbach's α coefficient for the total score was 0.79, the intraclass correlation was 0.85, and the factor analysis yielded a similar four factor solution as the original scale. Correlation for the test-re-test total score was 0.86. Total NEQ score was significantly correlated with the BDI-II (r=0.48 p<0.001), but this correlation was not significant during the test-re-test (r=0.28, p=0.10) or with STAI at either time point (0.05, p=0.40; r=0.07, p=0.69, respectively).
CONCLUSIONS: The Spanish version of the NEQ demonstrated adequate internal consistency for the majority of domains and excellent reproducibility. There was divergent validity with anxiety and a relationship between night eating and depression. These results suggest that the Spanish-version of the NEQ is an instrument that is valid for use in clinical research.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22664407     DOI: 10.1016/j.eatbeh.2012.02.005

Source DB:  PubMed          Journal:  Eat Behav        ISSN: 1471-0153


  7 in total

1.  Development, validation and reliability of the Chrononutrition Profile - Questionnaire.

Authors:  Allison C Veronda; Kelly C Allison; Ross D Crosby; Leah A Irish
Journal:  Chronobiol Int       Date:  2019-11-25       Impact factor: 2.877

2.  Night-eating symptoms and 2-year weight change in parents enrolled in the QUALITY cohort.

Authors:  A Gallant; J Lundgren; J O'Loughlin; K Allison; A Tremblay; M Henderson; V Drapeau
Journal:  Int J Obes (Lond)       Date:  2015-03-23       Impact factor: 5.095

Review 3.  Sleep and Eating Disorders.

Authors:  Kelly C Allison; Andrea Spaeth; Christina M Hopkins
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

Review 4.  Measurement properties of eating behavior self-assessment tools in adult bariatric surgery populations: a systematic review.

Authors:  Karen S Barclay; Paula W Rushton; Susan J Forwell
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

5.  Adaptation of the night eating questionnaire for Brazilian adolescents.

Authors:  Francisco Girleudo Coutinho da Silva; Thisciane Ferreira Pinto; Evanice Avelino de Souza; Veralice Meireles Sales de Bruin; Pedro Felipe Carvalhedo de Bruin
Journal:  Sleep Sci       Date:  2020 Apr-Jun

Review 6.  Optimal management of night eating syndrome: challenges and solutions.

Authors:  Suat Kucukgoncu; Margaretta Midura; Cenk Tek
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-19       Impact factor: 2.570

7.  En_Línea. An online treatment to change lifestyle in overweight and obesity: study protocol for a randomized controlled trial.

Authors:  Carmen Varela; Carmina Saldaña
Journal:  BMC Public Health       Date:  2019-11-21       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.